In head and neck squamous cell carcinoma (HNSCC), miR-200c suppresses HNSCC -associated cancer stem cells by targeting the 3′ UTR of BMI1, thereby reducing the tumor’s metastatic potential [52]. Here, BMI1 is linked to cancer.